Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas [Phase 1]

View source ↗

Summary

This clinical trial update reports on the safety and tolerability of MEDI-565 in adults with gastrointestinal adenocarcinoma in a Phase 1 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Adenocarcinoma

Drugs mentioned

• MEDI-565

Snippet

Sponsor: MedImmune LLC | Conditions: Gastrointestinal Adenocarcinomas | Phase 1 | Status: COMPLETED